Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Upgrades FibroGen to Outperform

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

byBenzinga Newsdesk

January 31, 2023

1 minute read

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

This Congresswoman Saw Returns Of Over 20% On An Aerospace Company; Check Out 3 Dividend Stocks She Recently Purchased

By Robert Kuczmarski

Today, 11:55 PM

The stock purchases of U.S. Representative Diana Harshbarger (R-TN) were first covered by Benzinga on Oct.

AZO

News

SiTime Introduces XCalibu For Timing Industry’s Supply Chain Disruption

By Benzinga Newsdesk

Today, 11:55 PM

SiTime Corporation (NASDAQ:SITM), a market leader in MEMS timing, today introduced the SiTime® XCalibur™ active resonator. This innovative new product category solves supply chain constraints using

SITM

Recap: SiteOne Landscape Supply Q4 Earnings

By Benzinga Insights

Today, 11:55 PM

SiteOne Landscape Supply (NYSE:SITE) reported its Q4 earnings results on Wednesday, February 16, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

SITE

Bluejay Diagnostics Q2 EPS $(0.10)

By Michael Horton

Today, 11:55 PM

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share.

BJDX

William Blair Upgrades FibroGen to Outperform

Related Posts

This Congresswoman Saw Returns Of Over 20% On An Aerospace Company; Check Out 3 Dividend Stocks She Recently Purchased

SiTime Introduces XCalibu For Timing Industry’s Supply Chain Disruption

Recap: SiteOne Landscape Supply Q4 Earnings

Bluejay Diagnostics Q2 EPS $(0.10)